Hock Tan, CEO of Broadcom (L) and former CEO of Intel, Pat Gelsinger.
Reuters | CNBC
It was a big year for silicon in Silicon Valley — but a brutal one for the company most responsible for the area’s moniker.
Intel, the 56-year-old chipmaker co-founded by industry pioneers Gordon Moore and Robert Noyce and legendary investor Arthur Rock, had its worst year since going public in 1971, losing 61% of its value.
The opposite story unfolded at Broadcom, the chip conglomerate run by CEO Hock Tan and headquartered in Palo Alto, California, about 15 miles from Intel’s Santa Clara campus.
Broadcom’s stock price soared 111% in 2024 as of Monday’s close, its best performance ever. The current company is the product of a 2015 acquisition by Avago, which went public in 2009.
The driving force behind the diverging narratives was artificial intelligence. Broadcom rode the AI train, while Intel largely missed it. The changing fortunes of the two chipmakers underscores the fleeting nature of leadership in the tech industry and how a few key decisions can result in hundreds of billions — or even trillions — of dollars in market cap shifts.
Broadcom develops custom chips for Google and other huge cloud companies. It also makes essential networking gear that large server clusters need to tie thousands of AI chips together. Within AI, Broadcom has largely been overshadowed by Nvidia, whose graphics processing units, or GPUs, power most of the large language models being developed at OpenAI, Microsoft, Google and Amazon and also enable the heftiest AI workloads.
Despite having a lower profile, Broadcom’s accelerator chips, which the company calls XPUs, have become a key piece of the AI ecosystem.
“Why it’s really shooting up is because they’re talking about AI, AI, AI, AI,” Eric Ross, chief investment strategist at Cascend, told CNBC’s “Squawk Box” earlier this month.
Intel, which for decades was the dominant U.S. chipmaker, has been mostly shut out of AI. Its server chips lag far behind Nvidia’s, and the company has also lost market share to longtime rival Advanced Micro Devices while spending heavily on new factories.
Intel’s board ousted Pat Gelsinger from the CEO role on Dec. 1, after a tumultuous four-year tenure.
“I think someone more innovative might have seen the AI wave coming,” Paul Argenti, professor of management at Dartmouth’s Tuck School of Business, said in an interview on “Squawk Box” after the announcement.
An Intel spokesperson declined to comment.
Broadcom is now worth about $1.1 trillion and is the eighth U.S. tech company to cross the trillion-dollar mark. It’s the second most valuable chip company, behind Nvidia, which has driven the AI boom to a $3.4 trillion valuation, trailing only Apple among all public companies. Nvidia’s stock price soared 178% this year, but actually did better in 2023, when it gained 239%.
Until four years ago, Intel was the world’s most valuable chipmaker, nearing a $300 billion market cap in early 2020. The company is now worth about $85 billion, just got booted off the Dow Jones Industrial Average — replaced by Nvidia — and has been in talks to sell off core parts of its business. Intel now ranks 15th in market cap among semiconductor companies globally.
‘Not meant for everybody’
Following the Avago-Broadcom merger in 2015, the combined company’s biggest business was chips for TV set-top boxes and broadband routers. Broadcom still makes Wi-Fi chips used in laptops as well as the iPhone and other smartphones.
After a failed bid to buy mobile chip giant Qualcomm in 2018, Broadcom turned its attention to software companies. The capstone of its spending spree came in 2022 with the announced acquisition of server virtualization software vendor VMware for $61 billion. Software accounted for 41% of Broadcom’s $14 billion in revenue in the most recent quarter, thanks in part to VMware.
What’s exciting Wall Street is Broadcom’s role working with cloud providers to build custom chips for AI. The company’s XPUs are generally simpler and less expensive to operate than Nvidia’s GPUs, and they’re designed to run specific AI programs efficiently.
Cloud vendors and other large internet companies are spending billions of dollars a year on Nvidia’s GPUs so they can build their own models and run AI workloads for customers. Broadcom’s success with custom chips is setting up an AI spending showdown with Nvidia, as hyperscale cloud companies look to differentiate their products and services from their rivals.
Broadcom’s chips aren’t for everyone, as only a handful of companies can afford to design and build their own custom processors.
“You have to be a Google, you have to be a Meta, you have to be a Microsoft or an Oracle to be able to use those chips,” Piper Sandler analyst Harsh Kumar told CNBC’s “Squawk on the Street” on Dec. 13, a day after Broadcom’s earnings. “These chips are not meant for everybody.”
While 2024 has been a breakout year for Broadcom — AI revenue increased 220% — the month of December has put it in record territory. The stock is up 45% for the month as of Monday’s close, 16 percentage points better than its prior best month.
On the company’s earnings call on Dec. 12, Tan told investors that Broadcom had doubled shipments of its XPUs to its three hyperscale providers. The most well known of the bunch is Google, which counts on the technology for its Tensor Processing Units, or TPUs, used to train Apple’s AI software released this year. The other two customers, according to analysts, are TikTok parent ByteDance and Meta.
Tan said that within about two years, companies could spend between $60 billion and $90 billion on XPUs.
“In 2027, we believe each of them plans to deploy 1 million XPU clusters across a single fabric,” Tan said of the three hyperscale customers.
In addition to AI chips, AI server clusters need powerful networking parts to train the most advanced models. Networking chips for AI accounted for 76% of Broadcom’s $4.5 billion of networking sales in the fourth quarter.
Broadcom said that, in total, about 40% of its $30.1 billion in 2024 semiconductor sales were related to AI, and that AI revenue would increase 65% in the first quarter to $3.8 billion.
“The degree of success amongst the hyperscalers in their initiatives here is clearly an area up for debate,” Cantor analyst C.J. Muse, who recommends buying Broadcom shares, wrote in a report on Dec. 18. “But any way you slice it, the focus here will continue to be a meaningful boon for those levered to custom silicon.”
Intel’s very bad year
Prior to 2024, Intel’s worst year on the market was 1974, when the stock sank 57%.
The seeds for the company’s latest stumbles were planted years ago, as Intel missed out on mobile chips to Qualcomm, ARM and Apple.
Rival AMD started taking market share in the critical PC and server CPU markets thanks to its productive manufacturing relationship with Taiwan Semiconductor Manufacturing Company. Intel’s manufacturing process has been a notch behind for years, leading to slower and less power-efficient central processing units, or CPUs.
But Intel’s most costly whiff is in AI — and it’s a big reason Gelsinger was removed.
Nvidia’s GPUs, originally created for video games, have become the critical hardware in the development of power-hungry AI models. Intel’s CPU, formerly the most important and expensive part in a server, has become an afterthought in an AI server. The GPUs Nvidia will ship in 2025 don’t even need an Intel CPU — many of them are paired to an Nvidia-designed ARM-based chip.
As Nvidia has reported revenue growth of at least 94% for the past six quarters, Intel has been forced into downsizing mode. Sales have declined in nine of the past 11 periods. Intel announced in August that it was cutting 15,000 jobs, or about 15% of its workforce.
“We are working to create a leaner, simpler, more agile Intel,” board Chair Frank Yeary said in a Dec. 2 press release announcing Gelsinger’s departure.
A big problem for Intel is that it lacks a comprehensive AI strategy. It’s touted the AI capabilities on its laptop chips to investors, and released an Nvidia competitor called Gaudi 3. But neither the company’s AI PC initiative nor its Gaudi chips have gained much traction in the market. Intel’s Gaudi 3 sales missed the company’s own $500 million target for this year.
Late next year, Intel will release a new AI chip that it codenamed Falcon Shores. It won’t be built on Gaudi 3 architecture, and will instead be a GPU.
“Is it going to be wonderful? No, but it is a good first step in getting the platform done,” Intel interim co-CEO Michelle Holthaus said at a financial conference held by Barclays on Dec. 12.
Holthaus and fellow interim co-CEO David Zinsner have vowed to focus on Intel’s products, leaving the fate of Intel’s costly foundry division unclear.
Before he left, Gelsinger championed a strategy that involved Intel both finding its footing in the semiconductor market and manufacturing chips to compete with TSMC. In June, at a conference in Taipei, Gelsinger told CNBC that when its factories get up and running, Intel wanted to build “everybody’s AI chips,” and give companies such as Nvidia and Broadcom an alternative to TSMC.
Intel said in September that it plans to turn its foundry business into an independent unit with its own board and the potential to raise outside capital. But for now, Intel’s primary client is Intel. The company said it didn’t expect meaningful sales from external customers until 2027.
At the Barclays event this month, Zinsner said the separate board for the foundry business is “getting stood up today.” More broadly, he indicated that the company is looking to remove complexity and associated costs wherever possible.
“We are going to constantly be scrutinizing where we’re spending money, making sure that we’re getting the appropriate return,” Zinsner said.
Paxton sued Google in 2022 for allegedly unlawfully tracking and collecting the private data of users.
The attorney general said the settlement, which covers allegations in two separate lawsuits against the search engine and app giant, dwarfed all past settlements by other states with Google for similar data privacy violations.
Google’s settlement comes nearly 10 months after Paxton obtained a $1.4 billion settlement for Texas from Meta, the parent company of Facebook and Instagram, to resolve claims of unauthorized use of biometric data by users of those popular social media platforms.
“In Texas, Big Tech is not above the law,” Paxton said in a statement on Friday.
“For years, Google secretly tracked people’s movements, private searches, and even their voiceprints and facial geometry through their products and services. I fought back and won,” said Paxton.
“This $1.375 billion settlement is a major win for Texans’ privacy and tells companies that they will pay for abusing our trust.”
Google spokesman Jose Castaneda said the company did not admit any wrongdoing or liability in the settlement, which involves allegations related to the Chrome browser’s incognito setting, disclosures related to location history on the Google Maps app, and biometric claims related to Google Photo.
Castaneda said Google does not have to make any changes to products in connection with the settlement and that all of the policy changes that the company made in connection with the allegations were previously announced or implemented.
“This settles a raft of old claims, many of which have already been resolved elsewhere, concerning product policies we have long since changed,” Castaneda said.
“We are pleased to put them behind us, and we will continue to build robust privacy controls into our services.”
Virtual care company Omada Health filed for an IPO on Friday, the latest digital health company that’s signaled its intent to hit the public markets despite a turbulent economy.
Founded in 2012, Omada offers virtual care programs to support patients with chronic conditions like prediabetes, diabetes and hypertension. The company describes its approach as a “between-visit care model” that is complementary to the broader health-care ecosystem, according to its prospectus.
Revenue increased 57% in the first quarter to $55 million, up from $35.1 million during the same period last year, the filing said. The San Francisco-based company generated $169.8 million in revenue during 2024, up 38% from $122.8 million the previous year.
Omada’s net loss narrowed to $9.4 million during its first quarter from $19 million during the same period last year. It reported a net loss of $47.1 million in 2024, compared to a $67.5 million net loss during 2023.
The IPO market has been largely dormant across the tech sector for the past three years, and within digital health, it’s been almost completely dead. After President Donald Trump announced a sweeping tariff policy that plunged U.S. markets into turmoil last month, taking a company public is an even riskier endeavor. Online lender Klarna delayed its long-anticipated IPO, as did ticket marketplace StubHub.
But Omada Health isn’t the first digital health company to file for its public market debut this year. Virtual physical therapy startup Hinge Health filed its prospectus in March, and provided an update with its first-quarter earnings on Monday, a signal to investors that it’s looking to forge ahead.
Omada contracts with employers, and the company said it works with more than 2,000 customers and supports 679,000 members as of March 31. More than 156 million Americans suffer from at least one chronic condition, so there is a significant market opportunity, according to the company’s filing.
In 2022, Omada announced a $192 million funding round that pushed its valuation above $1 billion. U.S. Venture Partners, Andreessen Horowitz and Fidelity’s FMR LLC are the largest outside shareholders in the company, each owning between 9% and 10% of the stock.
“To our prospective shareholders, thank you for learning more about Omada. I invite you join our journey,” Omada co-founder and CEO Sean Duffy said in the filing. “In front of us is a unique chance to build a promising and successful business while truly changing lives.”
Liz Reid, vice president, search, Google speaks during an event in New Delhi on December 19, 2022.
Sajjad Hussain | AFP | Getty Images
Testimony in Google‘s antitrust search remedies trial that wrapped hearings Friday shows how the company is calculating possible changes proposed by the Department of Justice.
Google head of search Liz Reid testified in court Tuesday that the company would need to divert between 1,000 and 2,000 employees, roughly 20% of Google’s search organization, to carry out some of the proposed remedies, a source with knowledge of the proceedings confirmed.
The testimony comes during the final days of the remedies trial, which will determine what penalties should be taken against Google after a judge last year ruled the company has held an illegal monopoly in its core market of internet search.
The DOJ, which filed the original antitrust suit and proposed remedies, asked the judge to force Google to share its data used for generating search results, such as click data. It also asked for the company to remove the use of “compelled syndication,” which refers to the practice of making certain deals with companies to ensure its search engine remains the default choice in browsers and smartphones.
Read more CNBC tech news
Google pays Apple billions of dollars per year to be the default search engine on iPhones. It’s lucrative for Apple and a valuable way for Google to get more search volume and users.
Apple’s SVP of Services Eddy Cue testified Wednesday that Apple chooses to feature Google because it’s “the best search engine.”
The DOJ also proposed the company divest its Chrome browser but that was not included in Reid’s initial calculation, the source confirmed.
Reid on Tuesday said Google’s proprietary “Knowledge Graph” database, which it uses to surface search results, contains more than 500 billion facts, according to the source, and that Google has invested more than $20 billion in engineering costs and content acquisition over more than a decade.
“People ask Google questions they wouldn’t ask anyone else,” she said, according to the source.
Reid echoed Google’s argument that sharing its data would create privacy risks, the source confirmed.
Closing arguments for the search remedies trial will take place May 29th and 30th, followed by the judge’s decision expected in August.
The company faces a separate remedies trial for its advertising tech business, which is scheduled to begin Sept. 22.